BioNTech

CAMBRIDGE, Mass. — Pharma giant Moderna sued Pfizer and BioNTech on Friday, claiming that their popular COVID vaccine was copied from groundbreaking science Moderna performed. In a statement posted on its website, Moderna said Pfizer and BioNTech infringed on patents... Read More

WASHINGTON — Pfizer and its German partner, BioNTech, asked the Food and Drug Administration Monday to authorize COVID booster shots that target the omicron BA.4 and BA.5 subvariants for people aged 12 and older. The request came less than a... Read More

Pfizer Inc. and BioNTech SE’s COVID-19 vaccine won the backing of the European medicines regulator, clearing the way for inoculations to start before the end of the year as the continent struggles with rising death rates and tighter lockdowns. The... Read More

Pfizer Inc. said a final analysis of clinical trial data showed its COVID-19 vaccine was 95% effective, paving the way for the company to apply this week for the first U.S. regulatory authorization for a coronavirus shot. The U.S. drugmaker and partner BioNTech SE said their vaccine... Read More